BioSpace News Archive

Increase in number of medication error-related deaths and stringent health care regulations have driven health care providers and retail pharmacists to focus on improving their outpatient services.

Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement.

Breast Biopsy tests are used largely for diagnosing breast cancer and also as a preventive checkup for breast cancer and other ailments in the breast, such as lump etc.

Behavior therapy, also known as behavior analytical and psychotherapy, is a term that broadly refers to the treatment that helps alter self-destructing behaviors in a patient.

Priority Medicines (PRIME) designation supports the potential for lacutamab to benefit Sézary Syndrome patients in need of new treatment options

Study Results Showed Long-term Findings Consistent with the Known Safety Profile of TAKHZYRO with Reductions in the Rate of HAE Attacks and Attack-free Periods

Promising long-term safety and effectiveness results from PAD population with extremely complex SFA disease

PureTech Health plc announced, further to the Company’s announcement on October 28, 2020, that it expects trading of American Depository Shares of the Company on the Nasdaq Global Market will commence on Monday, November 16, 2020, under the ticker symbol “PRTC” following Nasdaq’s approval of the ADSs for listing yesterday, November 12, 2020.

Observations of rapid recovery noted on chest x-ray and no drug-related Serious Adverse Events reported

I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced that it will hold a call with investors on Friday, November 13 at 8:20 a.m. ET to provide deep dive analysis of preliminary clinical efficacy results of its U.S.